Correct me if I'm wrong but isn't this the first time we're hearing about using BTX1801 for treatment for patients using a dialysis machine? If successful, this would prove antimicrobial effect systemically in the bloodstream which would open a pathway for use in all patients with any infection not just people with kidney issues. Thinking out loud here..
Ann: Botanix Update on BTX 1801 Clinical Development, page-4
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.005M | 2.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 312537 | 10 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |